Exploring 5-Deazaflavin, Mitochondrial Function, and the Science of Cellular Energy
Mitochondria play an essential role in how cells produce and manage energy. Because their function can change with age, researchers are investigating compounds that may influence mitochondrial activity and cellular energy processes.
One emerging compound attracting scientific interest is TND1128, also known as a 5-deazaflavin derivative.
Unlike more familiar ingredients such as NMN and nicotinamide riboside (NR), TND1128 has a relatively limited research history. Early laboratory and animal studies have investigated its redox properties, mitochondrial activity, and potential effects on neuronal cells.
But what exactly is TND1128? What have researchers discovered so far? And how much of this research can be applied to human health?
Let's explore the available evidence and take a closer look at Aeternum TND1128 100 mg Capsules.
1. What Is TND1128?
TND1128 is a synthetic compound identified in scientific publications as a derivative of 5-deazaflavin.
Its chemical name is 10-ethyl-3-methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione.
Researchers have investigated TND1128 because of its redox properties and its potential involvement in mitochondrial energy metabolism.
Redox reactions involve the transfer of electrons between molecules. These reactions are fundamental to many biological processes, including the pathways mitochondria use to produce adenosine triphosphate (ATP).
ATP is the molecule cells use to store and transfer energy for essential activities.
TND1128 has been described in research as having NAD+-like or self-redox properties. This has led scientists to investigate whether it can influence mitochondrial activity through mechanisms that differ from conventional NAD+ precursors.
However, it is important to distinguish a proposed mechanism from an established human benefit.
TND1128 is an emerging research compound, and its effects in humans have not been established through adequate clinical trials.
2. Why Are Researchers Interested in Mitochondria?
Mitochondria are structures inside cells that help produce ATP through cellular respiration.
They are especially important in tissues with high energy requirements, including the brain, heart, and skeletal muscles.
The process involves several interconnected pathways, including the tricarboxylic acid cycle (TCA cycle) and the electron transport chain.
These pathways work together to support ATP production.
One important feature of mitochondrial function is the mitochondrial membrane potential.
What Is Mitochondrial Membrane Potential?
Mitochondria maintain an electrical and chemical gradient across their inner membrane.
This gradient provides the driving force for ATP production through a process called oxidative phosphorylation.
Researchers measure mitochondrial membrane potential to investigate how mitochondria respond to different conditions and compounds.
Changes in this measurement can provide information about mitochondrial activity, but they do not independently establish that a substance improves overall health or physical performance.
This is one reason TND1128 has attracted scientific attention: researchers are investigating whether its redox properties influence mitochondrial membrane potential and energy-related processes.
3. What Did the First TND1128 Study Find?
An early study published in Biochemical and Biophysical Research Communications in 2021 investigated TND1128 in cultured mouse hippocampal neurons.
The hippocampus is a brain region involved in learning, memory, and other cognitive functions.
Researchers examined how TND1128 affected the development and structure of these cultured neurons.
They reported several observations:
- Increased branching of neuronal axons.
- Increased branching of dendrites.
- An increased number of excitatory synapses.
- Differences in neuronal development compared with untreated cultures.
The researchers also compared TND1128 with beta-nicotinamide mononucleotide (β-NMN).
These findings provided an early indication that TND1128 may influence neuronal morphology under laboratory conditions.
However, the experiment used cultured mouse neurons. It did not demonstrate improved memory, concentration, or cognitive performance in humans.
Changes in neuronal structure in a laboratory model cannot automatically be translated into improvements in human brain function.
Research reference:
Katsurabayashi S, et al. (2021). The Novel Mitochondria Activator, 10-Ethyl-3-Methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione (TND1128), Promotes the Development of Hippocampal Neuronal Morphology.
4. What Did Researchers Discover About TND1128 and Mitochondrial Activity?
A second study published in the Journal of Pharmacological Sciences in 2023 investigated TND1128 using mouse brain slices.
Researchers compared TND1128 with β-NMN and examined changes in calcium concentrations inside neurons and mitochondria.
Calcium plays several important roles in cellular signaling. However, excessive calcium accumulation can disrupt normal cellular processes.
The researchers found that TND1128 mitigated certain calcium-related changes in the experimental preparations in a dose-dependent manner.
The study also reported differences between TND1128 and β-NMN in their effects on mitochondrial calcium dynamics.
These findings suggested that TND1128 may influence mitochondrial activity and calcium handling through mechanisms worth investigating further.
What does this mean?
The study provides experimental evidence of an effect in mouse brain tissue. It does not establish that TND1128 improves brain health or protects against neurodegenerative diseases in humans.
Research reference:
Takahashi N, et al. (2023). Effects of TND1128 (a 5-Deazaflavin Derivative), With Self-Redox Ability, as a Mitochondria Activator on the Mouse Brain Slice and Its Comparison With β-NMN.
5. What Did the 2024 Study Reveal About ATP-Related Activity?
A further study published in 2024 investigated TND1128 and its relationship with mitochondrial membrane potential and ATP-related activity.
Researchers used brain slices from mice that had been pretreated with TND1128.
They examined mitochondrial membrane potential and how it responded when neuronal activity increased.
The researchers reported that:
- TND1128 increased mitochondrial membrane potential under certain experimental conditions.
- The compound influenced mitochondrial responses during increased neuronal activity.
- The researchers observed dose- and time-dependent effects on their ATP synthesis index.
- Changes in calcium responses were also observed in the experimental preparations.
The researchers proposed that TND1128 could participate in mitochondrial metabolic and electron-transfer processes, potentially facilitating ATP synthesis when energy demand increases.
This is an interesting direction for mitochondrial research.
However, the study used mouse brain slices and an experimental index of ATP-related activity. It was not a human clinical trial measuring daily energy, endurance, cognitive performance, or longevity.
Further research is needed to determine whether these findings translate into meaningful effects in living humans.
Research reference:
Takahashi N, et al. (2024). TND1128, a 5-Deazaflavin Derivative With Auto-Redox Ability, Facilitates Polarization of Mitochondrial Membrane Potential (ΔΨm) and On-Demand ATP Synthesis in Mice Brain Slices.
6. How Is TND1128 Different From NMN?
NMN and TND1128 are both discussed in research related to cellular energy metabolism, but they should not be treated as interchangeable ingredients.
NMN: A NAD+ Precursor
Nicotinamide mononucleotide (NMN) is a naturally occurring molecule involved in the NAD+ production pathway.
NAD+ is a coenzyme that participates in numerous cellular reactions, including energy metabolism and redox processes.
Researchers have investigated NMN supplementation in human studies, including trials examining blood NAD+ levels and selected health-related outcomes.
TND1128: A 5-Deazaflavin Derivative
TND1128 is a synthetic 5-deazaflavin derivative investigated for its redox properties and potential effects on mitochondrial activity.
Its proposed mechanism differs from the conventional NMN-to-NAD+ pathway.
Early experimental studies have examined its effects on mitochondrial membrane potential, calcium handling, and neuronal structure.
Why the Difference Matters
NMN has a larger body of human supplementation research than TND1128.
TND1128 has promising early experimental findings, but there is not yet sufficient human clinical evidence to establish its effects, appropriate supplementation levels, long-term safety, or comparative effectiveness.
Therefore, claims that TND1128 is definitively more potent or more effective than NMN in people are not established by the published studies discussed here.
7. What Does the Research Still Need to Answer?
TND1128 is an interesting research subject, but several important questions remain unanswered.
Does it produce similar effects in humans?
The published studies discussed above used cultured mouse neurons and mouse brain tissue. Human clinical trials are needed to determine whether the observed effects occur in people.
Does it meaningfully influence human NAD+ levels?
Although TND1128 has been described as having NAD+-like or self-redox properties, the available studies do not establish that oral supplementation increases NAD+ levels in humans.
What is its long-term safety profile?
Human safety, tolerability, interactions with medications, and long-term supplementation effects require appropriate clinical investigation.
What is the appropriate human dose?
Animal experimental doses cannot be directly converted into a recommended human supplement dose without appropriate pharmacological and clinical research.
Does it improve meaningful health outcomes?
Changes in mitochondrial membrane potential or ATP-related laboratory measurements do not automatically demonstrate improved energy, memory, endurance, or healthy lifespan.
These questions are essential when evaluating an emerging ingredient.
The most responsible way to interpret TND1128 research is to recognize what has been observed experimentally while acknowledging what remains unknown.
8. Meet Aeternum TND1128 100 mg Capsules
For people interested in emerging research on 5-deazaflavin and mitochondrial biology, Aeternum TND1128 offers a capsule formulation featuring this ingredient.
According to the product's current listing, each capsule contains:
TND1128 (5-deazaflavin): 100 mg
The product is presented in a 60-capsule bottle.
The listed ingredient information also identifies the product as free from GMOs, gluten, caffeine, artificial additives, and animal-derived ingredients.
Aeternum provides access to product testing documentation through its certificates page, allowing customers to review available information about ingredient identity and quality.
What Should You Review Before Choosing TND1128?
When exploring a relatively new ingredient, look beyond marketing descriptions.
Consider reviewing:
- The amount of TND1128 per capsule.
- The complete ingredient and excipient information.
- Available third-party testing documentation.
- The identity and purity testing methods.
- The manufacturer's safety and usage information.
- The published research and its limitations.
The 100 mg listed on the Aeternum product label describes the amount in each capsule. It should not be interpreted as a clinically established or universally appropriate human dose.
The published mouse and cell studies also do not establish that Aeternum TND1128 produces the same effects in humans.
9. What Does This Mean for the Future of TND1128 Research?
The early research on TND1128 provides several interesting observations.
Scientists have investigated its effects on neuronal development, mitochondrial membrane potential, calcium handling, and ATP-related activity in experimental models.
These studies contribute to a developing understanding of how 5-deazaflavin derivatives may interact with cellular energy processes.
However, the gap between experimental findings and proven human benefits remains significant.
Future research will need to establish human pharmacokinetics, appropriate dosing, safety, tolerability, and meaningful clinical outcomes.
Until then, TND1128 should be viewed as an emerging research ingredient rather than a clinically proven solution for increasing energy, improving cognition, or slowing aging.
Understanding that distinction is an important part of making informed decisions about longevity supplements.
Explore Aeternum TND1128
Interested in learning more about 5-deazaflavin and the research surrounding mitochondrial activity?
Aeternum TND1128 100 mg Capsules provide a defined amount of TND1128 per capsule, with product information and available testing documentation for customers to review.
Explore the formulation, ingredient details, and supporting research before deciding whether it aligns with your personal wellness interests.
Discover Aeternum TND1128 100 mg Capsules
EXPLORE TND1128 PRODUCT INFORMATION AND TESTING DETAILS
You can also review Aeternum's available product certificates and testing documentation.
Check current availability and shipping options for your region before ordering.
The science of TND1128 is still developing. The most valuable approach is to stay curious, examine the evidence, and understand the difference between promising experimental findings and proven human outcomes.
Frequently Asked Questions
What is TND1128?
TND1128 is a synthetic 5-deazaflavin derivative investigated for its redox properties and potential effects on mitochondrial activity.
Is TND1128 the same as NMN?
No. NMN is a precursor involved in NAD+ biosynthesis, while TND1128 is a 5-deazaflavin derivative investigated for its redox and mitochondrial effects. Their proposed mechanisms are different.
Does TND1128 increase ATP production?
Experimental research using mouse brain slices reported changes in mitochondrial membrane potential and an ATP synthesis index. These findings do not establish that TND1128 increases ATP production or physical energy in humans.
Has TND1128 been tested in human clinical trials?
The published studies discussed in this article involve cultured mouse neurons and mouse brain tissue. They do not establish human efficacy or safety. Adequate human clinical research is still needed.
Is TND1128 proven to improve memory or focus?
No. Although one experimental study observed changes in cultured mouse neuronal branching and excitatory synapse numbers, this does not demonstrate improved memory or focus in people.
How much TND1128 is in Aeternum's capsules?
The product listing specifies 100 mg of TND1128 (5-deazaflavin) per capsule.
Is TND1128 more effective than NMN?
There is currently insufficient human clinical evidence to establish that TND1128 is more effective or more potent than NMN in people. Experimental comparisons should not be presented as proof of superior human outcomes.
Scientific References
- Katsurabayashi S, et al. (2021). The Novel Mitochondria Activator, 10-Ethyl-3-Methylpyrimido[4,5-b]quinoline-2,4(3H,10H)-dione (TND1128), Promotes the Development of Hippocampal Neuronal Morphology. PubMed.
- Takahashi N, et al. (2023). Effects of TND1128 (a 5-Deazaflavin Derivative), With Self-Redox Ability, as a Mitochondria Activator on the Mouse Brain Slice and Its Comparison With β-NMN. PubMed.
- Takahashi N, et al. (2024). TND1128, a 5-Deazaflavin Derivative With Auto-Redox Ability, Facilitates Polarization of Mitochondrial Membrane Potential (ΔΨm) and On-Demand ATP Synthesis in Mice Brain Slices. PubMed.
This article is for educational purposes only and is not medical advice. TND1128's safety and effectiveness as a human supplement have not been established by the experimental studies discussed here. The research does not establish an appropriate human dose, long-term safety, or benefits for any medical condition. Consult a qualified healthcare professional before considering an emerging supplement, particularly if you take medication or have an existing medical condition.